Showing 160 Result(s)

It’s crucial to accelerate research on the safety of medical AI immediately.

Key Takeaways The FDA has relaxed requirements for clinical decision support (CDS) tools, allowing certain AI tools to enter clinics without stringent approval. New AI advancements include a pilot program in Utah for automated prescription refills and OpenAI’s ChatGPT Health for personalized responses. These developments aim to improve patient access to health advice and streamline …

Menopause Hormone Therapy Is Being Oversold Once More

Understanding Menopausal Hormone Therapy: What Women Need to Know Navigating the world of health information can be overwhelming, especially on social media. If you’re a woman transitioning through menopause, you may have seen claims that a single therapy can handle everything from wrinkles to heart health. Let’s break down the hype surrounding menopausal hormone therapy …

Cytokinetics’ cardiac medication receives FDA approval, marking a first for the biotech company.

Cytokinetics Achieves Milestone with U.S. Drug Approval Cytokinetics, a biotech company, has officially secured its first drug approval in the United States after 27 years of work. This significant achievement highlights the challenges and triumphs in the world of drug development. Here’s what you need to know about this exciting news. Key Takeaways Drug Approval: …

FDA Navigates Workforce Cuts and Political Struggles While Tackling Three Major Challenges in 2026 | STAT

Key Takeaways The FDA is facing significant leadership challenges ahead of 2026. High-profile departures and internal conflicts have lowered employee morale and stability. The future of FDA Commissioner Marty Makary is uncertain, raising concerns among key officials. The Food and Drug Administration, or FDA, is navigating a tricky landscape as it approaches 2026. Recent months …

FDA Voucher Program Has Resulted in Political Overreach in Drug Evaluations, According to Staff Members

Key Takeaways A new FDA program is allowing political influence over drug reviews. Historically, reviews were managed by career scientists to prevent interference. High-ranking officials are involved in deciding which drugs get expedited reviews. This shift raises concerns about the safety and efficacy processes for medications. Introduction The world of pharmaceuticals can be complex, and …